Showing results (41-50 of 87) with videos related to
Sort By:
Pageof 9
Cancer Research|April 3, 2008
Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumorsAndrea Worschech, Maciej Kmieciak, Keith L Knutson, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 15, 2011
Activated NKT cells and NK cells render T cells resistant to myeloid-derived suppressor cells and result in an effective adoptive cellular therapy against breast cancer in the FVBN202 transgenic mouseMaciej Kmieciak, Debasmita Basu, Kyle K Payne, et al.Nuclear Medicine and Biology|October 9, 2007
Imaging multidrug resistance with 4-[18F]fluoropaclitaxelKaren A Kurdziel, Joseph D Kalen, Jerry I Hirsch, et al.Cancers|July 12, 2025
Correction: Shen et al. Neighborhood Disadvantage, Built Environment, and Breast Cancer Outcomes: Disparities in Tumor Aggressiveness and Survival. Cancers 2025, 17, 1502Jie Shen, Yufan Guan, Supraja Gururaj, et al.Cancers|May 14, 2025
Neighborhood Disadvantage, Built Environment, and Breast Cancer Outcomes: Disparities in Tumor Aggressiveness and SurvivalJie Shen, Yufan Guan, Supraja Gururaj, et al.Plos One|October 22, 2014
Near-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labelingFatma M Youniss, Gobalakrishnan Sundaresan, Laura J Graham, et al.JAMA Network Open|August 21, 2025
Allostatic Load and Racial and Rural Disparities in Breast Cancer SurvivalYufan Guan, Roger T Anderson, Supraja Gururaj, et al.Breast Cancer Research and Treatment|July 14, 2011
A gene transcription signature of obesity in breast cancerChad J Creighton, Yvonne H Sada, Yiqun Zhang, et al.Journal of Leukocyte Biology|March 2, 2016
Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cellsKyle K Payne, Rebecca C Keim, Laura Graham, et al.Breast Cancer Research and Treatment|November 8, 2013
Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cellsKyle K Payne, Christine K Zoon, Wen Wan, et al.Pageof 9